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Abstract Cyclosporin A (CsA) inhibits the mitochondrial
permeability transition (MPT), but not always. To characterize
the CsA-sensitive and -insensitive MPT, rat liver mitochondria
were exposed to low and high doses of various MPT inducers.
Mitochondrial swelling, cyclophilin D membrane binding and
permeability transition (PT) pore diameter were measured. The
results indicate two conductance modes for the PT pore: one
activated by Ca2+ and inhibited by CsA and Mg2+ and the other
unregulated. We propose a new model of pore formation and
gating in which PT pores form by aggregation of misfolded
integral membrane proteins damaged by oxidant and other
stresses. Chaperone-like proteins initially block conductance
through these misfolded protein clusters; however, increased
Ca2+ opens these regulated PT pores, an effect blocked by CsA.
When protein clusters exceed chaperones available to block
conductance, unregulated pore opening occurs. ß 2002 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
Key words: Rat liver mitochondrion; Cyclophilin D;
Cyclosporin A; Calcium; Amphipathic peptide;
Oxidant chemical
1. Introduction
Opening of high conductance permeability transition (PT)
pores induces the mitochondrial PT (MPT), which is charac-
terized by mitochondrial swelling, uncoupling and inner mem-
brane permeabilization to solutes up to 1500 Da [1]. Ca2
induces pore opening, whereas Mg2 and cyclosporin A
(CsA) close the pore. PT pores play an important pathogenic
role in both necrotic and apoptotic cell death (reviewed in
[2,3]). The molecular composition and regulation of PT pores,
however, remain poorly understood. A current model suggests
that PT pores form at contact sites between the mitochondrial
inner and outer membranes by association of the voltage-de-
pendent anion channel (VDAC) in the outer membrane, the
adenine nucleotide translocator (ANT) in the inner mem-
brane, cyclophilin D (CypD) in the matrix, and possibly other
proteins [4,5]. This working model is consistent with inhibi-
tion and activation of the MPT by bongkrekic acid and atrac-
tyloside, ligands of ANT, and blockade by CsA, which binds
to CypD [6,7].
Several experimental ¢ndings are di⁄cult to explain by this
model of PT pore structure. First, although Ca2-dependent
activation and CsA inhibition of the MPT are considered
hallmarks of the MPT, the MPT can also occur in the absence
of Ca2 [8^10], and inhibition of the MPT by CsA can be
transitory or ine¡ective [9]. Second, although oxidative stress
is reported to induce CypD binding to mitochondrial mem-
branes [11^13], VDAC and ANT bind tightly to CypD a⁄nity
columns in the absence of Ca2 and exogenous oxidant [5].
Third, although PT pore-like conductance can be reconsti-
tuted with ANT alone, ANT in combination with VDAC
and CypD, and ANT plus other proteins [5,14,15], other pu-
ri¢ed mitochondrial anion carriers, such as the aspartate/glu-
tamate and phosphate carriers, can also be converted to un-
speci¢c pores [16^18]. Fourth, small exogenous amphipathic
peptides and the mitochondrial matrix targeting sequence of
cytochrome c oxidase subunit IV (COX IV) induce an MPT in
mitochondria that is inhibited by CsA [8,19]. Lastly, although
PT pores are often assumed to be a normal constituent of
mitochondrial membranes, induction of the MPT typically
requires mitochondrial membrane damage, such as from oxy-
gen radical attack and protein disul¢de cross-linking [20]. Be-
cause of the discrepant literature, we reconsider the basic
properties of PT pore physiology. Here, we present data in-
dicating that PT pores opened by any of several inducers
operate in two modes, a regulated mode that is activated by
Ca2 and inhibited by CsA and Mg2 and an unregulated
mode that is Ca2-independent and insensitive to CsA and
Mg2. To account for the two modes of pore conductance
and other features of pore physiology, we propose a new
model of PT pore formation and regulation.
2. Materials and methods
Rat liver mitochondria were isolated in 250 mM sucrose, 2 mM
K-HEPES bu¡er, pH 7.4, as described [21]. Mitochondrial swelling
was monitored at 25‡C by absorbance at 540 nm with a ThermoMax
96-well plate reader (Molecular Devices, Sunnyvale, CA, USA) in
incubation bu¡er containing 200 mM sucrose, 20 WM EGTA, 5 mM
succinate, 2 WM rotenone, 1 Wg/ml oligomycin, 20 mM Tris, 20 mM
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HEPES and 1 mM KH2PO4, pH 7.2. PT pore size was estimated by
solute exclusion using polyethylene glycol (PEG) of various molecular
weights (0.4^8 kDa), as described [8].
To chelate endogenous mitochondrial Ca2, mitochondria were ¢rst
incubated with 100 WM EGTA-AM for 30 min at room temperature.
The EGTA-loaded mitochondria were then centrifuged at 10 000Ug
and resuspended in incubation bu¡er. Fluorescence of the Ca2 in-
dicator, Fluo-5N (1 WM), and absorbance were determined in a £uo-
rescence plate reader (BMG LabTechnologies GmbH, O¡enburg,
Germany), as described [22].
To determine CypD membrane binding, mitochondria were frozen
in liquid nitrogen, thawed and sonicated on ice. The sonicate was
centrifuged at 10 000Ug for 20 min at 4‡C, and the resulting super-
natant was centrifuged at 150 000Ug for 1 h at 4‡C to pellet the
membrane fraction. Membrane protein (20 Wg) was resolved by 15%
SDS^polyacrylamide gel electrophoresis and transferred to a PVDF
membrane. Western blotting was carried out, and signals were de-
tected using ECL Plus (Amersham, Piscataway, NJ, USA) and a gel
imaging system (Molecular Dynamics, Sunnyvale, CA, USA). Pri-
mary antibody raised against the N-terminal peptide of the CypD
that only recognizes mitochondrial cyclophilin [23] was custom-syn-
thesized by Bethyl Laboratory (Montgomery, TX, USA). To assess
equal loading of proteins, blots were stripped and reprobed with
mouse anti-COX IV antibody (Molecular Probes, Eugene, OR, USA).
3. Results and discussion
3.1. Low doses of inducers cause a Ca2+-dependent MPT that
is inhibited by CsA and Mg2+, whereas high doses induce a
Ca2+-independent and CsA- and Mg2+-insensitive MPT
In the classically de¢ned MPT, an inducer in the presence
of Ca2 initiates large amplitude mitochondrial swelling after
a time interval of several seconds or minutes. Fig. 1 illustrates
this behavior for HgCl2. Although neither 5 WM HgCl2 nor
50 WM CaCl2 alone induced mitochondrial swelling (data not
shown), CaCl2 plus HgCl2 produced marked mitochondrial
swelling that reached a maximum after 8 min (Fig. 1A, trace
a). CsA (1 WM), EGTA (0.5 mM) and MgCl2 (5 mM) com-
pletely inhibited this swelling (traces b, c and d, respectively).
However, at a higher dose of HgCl2 (20 WM), large amplitude
mitochondrial swelling occurred rapidly in the absence of
added CaCl2 (Fig. 1B, trace a) and was not prevented by
CsA or EGTA (traces b and c, respectively). MgCl2 also did
not block swelling, although it did decrease the magnitude of
the absorbance change by about a third (trace d). Similar
results were obtained with low (100 nM) and high doses
(200 WM) of phenylarsine oxide (PhAsO), a thiol cross-linker
agent ([24], data not shown).
Pore-forming amphipathic peptides like alamethicin and
mastoparan have been reported to induce mitochondrial
swelling that resembles the MPT [8]. As shown in Fig. 1C,
alamethicin at 50 nM induced swelling that required Ca2 and
was blocked by CsA, MgCl2 and EGTA. By contrast, a higher
dose of alamethicin (1 WM) caused swelling that did not re-
quire Ca2 and which was not blocked by CsA, EGTA or
MgCl2, although MgCl2 decreased the magnitude of the ab-
sorbance change by about 30% (Fig. 1D). Similar results were
obtained with low (1 WM) and high (4 WM) doses of masto-
paran (data not shown).
To assure that swelling after high-dose induction of the
MPT was not caused by endogenous Ca2, mitochondria
were ester-loaded with EGTA. As shown in Fig. 2A, in
sham-loaded mitochondria (trace a), 20 WM HgCl2 produced
a small but rapid increase in extramitochondrial Fluo-5N
Fig. 1. Opening of regulated and unregulated PT pores by HgCl2 and alamethicin. Mitochondria (0.5 mg protein/ml) were added to incubation
bu¡er, and onset of the MPT was monitored by absorbance, as described in Section 2. After 2^3 min pre-incubation, 5 WM HgCl2 plus 50 WM
CaCl2 (A), 20 WM HgCl2 (B), 50 nM alamethicin plus 50 WM CaCl2 (C), and 1 WM alamethicin (D) were added. From the beginning of the in-
cubations, 1 WM CsA (traces b), 0.5 mM EGTA (traces c), or 5 mM MgCl2 (traces d) was present or no additions were made (traces a). The
data shown represent four independent experiments.
FEBS 25694 8-2-02
L. He, J.J. Lemasters/FEBS Letters 512 (2002) 1^72
£uorescence, which re£ects the release of endogenous Ca2
after onset of the MPT. By contrast, EGTA-loaded mitochon-
dria did not release Ca2 (trace b), indicating that EGTA had
chelated all measurable endogenous Ca2. Nonetheless, swell-
ing occurred in EGTA-loaded mitochondria to the same ex-
tent as sham-loaded mitochondria after 20 WM HgCl2,
although swelling did not occur in the absence of HgCl2
(Fig. 2B). These results con¢rm that the MPT induced by
high-dose HgCl2 was fully Ca2-independent. To assure that
EGTA was loaded into the mitochondria matrix and not sim-
ply added to the extramitochondrial space, mitochondria were
pre-incubated with 0.1 WM ruthenium red, which blocks Ca2
uptake by the uniporter. In the presence of ruthenium red, the
increase in Fluo-5N £uorescence after the addition of 50 WM
CaCl2 was the same in sham-loaded mitochondria as in
EGTA-loaded mitochondria (Fig. 2C), indicating that incuba-
tion with EGTA-AM did not cause chelation of Ca2 outside
of the mitochondria.
In our incubation bu¡er, CaCl2 alone at concentrations
between 100 and 500 WM induced swelling that was com-
pletely blocked by 1 WM CsA (data not shown), whereas
1 mM CaCl2 induced swelling that was not blocked by 1^10
WM CsA (Fig. 2D and data not shown). Swelling was not
driven osmotically by CaPi uptake after high-dose CaCl2, be-
cause in the presence of CsA mitochondria initially took up
the added Ca2 without swelling. Rather, swelling occurred as
mitochondria released Ca2, as measured by Fluo-5N, which
Fig. 2. Induction of PT pores by high-dose HgCl2 after chelation of endogenous Ca2 and by a high dose of CaCl2 in the presence of CsA. In
A^C, mitochondria (0.5 mg protein/ml) were sham-loaded or ester-loaded with EGTA and resuspended in incubation bu¡er. Free Ca2 and mi-
tochondria swelling were then measured simultaneously from Fluo-5N (1 WM) £uorescence (A) and absorbance (B), respectively, after addition
of 20 WM HgCl2 (traces a and b) or no addition (trace c), as described in Section 2. In C, mitochondria were pre-incubated for 1 min with
0.1 WM ruthenium red, and 50 WM CaCl2 was added to show the response of Fluo-5N to Ca2. Traces a are sham-loaded mitochondria, and
traces b and c are EGTA-loaded mitochondria. In D, 1 mM CaCl2 was added to mitochondria in the absence (traces a and aP) or presence
(traces b and bP) of 10 WM CsA. Mitochondrial swelling (solid lines) and extramitochondrial free Ca2 (dotted lines) were measured simulta-
neously.
Fig. 3. PEG exclusion by regulated and unregulated PT pores. Mi-
tochondria (0.5 mg protein/ml) were incubated at 25‡C in a sucrose-
based incubation bu¡er medium in which 40% of the total osmotic
pressure was derived from PEGs of a molecular weight from 0.4 to
8 kDa. The molecular weight of PEG causing 50% inhibition of the
absorbance change was determined. MPT was induced by 50 WM
CaCl2 plus low doses (white bars) of HgCl2 (5 WM), PhAsO
(100 nM), mastoparan (1 WM) and alamethicin (50 nM), and high
doses (black bars) of HgCl2 (20 WM), PhAsO (200 WM), mastoparan
(4 WM) and alamethicin (1 WM) without added CaCl2. Error bars
are standard deviations from four or ¢ve determinations. *P6 0.01
vs. low-dose alamethicin.
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is consistent with MPT-induced swelling (Fig. 2D). Thus,
Ca2 at low and high doses was also able to induce CsA-
sensitive and -insensitive PT pore opening.
Although the consensus of most reviews is that onset of the
MPT is critically dependent on Ca2 and is inhibited by CsA
[25^27], our observations that the MPT can become indepen-
dent of Ca2 and insensitive to CsA actually con¢rm individ-
ual ¢ndings in several previous reports. For example, it was
reported previously that a low concentration (1 WM) of mas-
toparan induced an MPT that was Ca2-dependent and CsA-
sensitive, while a high concentration (3 WM) of mastoparan
induced an MPT that was Ca2-independent and CsA-insen-
sitive [8]. Alamethicin at a high concentration (1.8 WM) also
caused Ca2-independent mitochondrial swelling. It was pro-
posed that low-dose mastoparan directly caused PT pore
opening, whereas high-dose alamethicin and mastoparan pro-
duced inner membrane permeabilization via a direct e¡ect on
the lipid bilayer [8]. In another study, low-dose (3 WM) gan-
glioside GD3 induced an MPT that required exogenous Ca2
and was blocked by CsA, while high-dose (100 WM) ganglio-
side GD3 in the presence of succinate induced an MPT that
was independent of elevated Ca2 and not prevented by CsA
[9]. Several studies showed non-classical MPT behavior after
exposure of mitochondria to oxidant chemicals. For example,
after exposure of mitochondria to tert-butyl hydroperoxide,
CsA delayed but did not prevent onset of mitochondrial swell-
ing [28]. In other studies, PhAsO at high concentrations (60
WM^1 mM) but not low concentrations (10^15 WM) induced
an MPT that was independent of Ca2, although sensitivity to
inhibition by CsA was partially if not fully retained [9,24].
Similarly, we observed that a high dose of HgCl2 (20 WM)
and PhAsO (200 WM) also produced Ca2-independent mito-
chondrial swelling (Fig. 1B and data not shown). Although
CsA did not prevent the MPT in our experiments, close in-
spection of the traces reveals that CsA did delay slightly the
onset of the MPT and decrease the initial rate of swelling both
with high-dose HgCl2 (Fig. 1B, trace b) and PhAsO (data not
shown), which may be consistent with the earlier studies.
Taken together, these observations indicate that the classi-
cal description of PT pore behavior is incomplete. We propose
that the PT pore has two functional modes: a regulated mode
activated by Ca2 and inhibited by CsA and Mg2, and an
unregulated mode that is Ca2-independent and insensitive to
CsA and Mg2. In general, a low level of MPT induction
opens regulated pores, whereas stronger MPT induction opens
unregulated pores. Therefore, a basic but generally unrecog-
nized feature of the MPT is its ability to transform from a
Ca2-dependent and CsA-sensitive event to a Ca2-indepen-
dent and CsA-insensitive event as the strength of MPT induc-
tion increases.
3.2. Regulated and unregulated PT pores opened by the same
inducers have similar PEG exclusion limits except for
alamethicin
Regulated and unregulated pores after MPT induction
could represent di¡erent functional states of the same pore
or two altogether di¡erent pores. To address this issue, we
determined the mean size of regulated and unregulated PT
pores formed after di¡erent inducers based on exclusion of
PEG of various molecular weights, as described by Pfei¡er
et al. [8]. The molecular weight of PEG that caused 50% in-
hibition of swelling was plotted for each MPT inducer at a
low dose in the presence of 50 WM CaCl2 and at a high dose
in the absence of CaCl2 (Fig. 3). Low and high doses of
HgCl2, PhAsO, mastoparan and alamethicin produced PT
pores with 50% PEG exclusion limits of 800^1400 Da. Anal-
ysis of variance and post hoc analysis using the Tukey^
Kramer multiple comparisons test revealed that average
pore size after low induction was not signi¢cantly di¡erent
for the four di¡erent inducers (Ps 0.05). Average pore size
was also not di¡erent between low and high doses of the
inducers, except for alamethicin, which produced a V50%
larger pore at a high dose (1400 vs. 900 Da, P6 0.01). These
results extend and con¢rm the earlier ¢ndings of Pfei¡er et al.
[8] showing that PT pores induced by low (1 WM) and high
(3 WM) concentrations of mastoparan are of similar average
size, which is smaller than the average size of pores induced
by high-dose alamethicin. Kinetic analysis of mitochondrial
swelling after MPT induction also shows that increasing con-
centrations of PhAsO do not change mean pore size, although
pore number increases [29]. The near identity of pore size after
low- and high-dose MPT induction with HgCl2, PhAsO and
mastoparan is consistent with the idea that regulated and un-
regulated pores represent two functional modes of the same
pore.
3.3. CypD binding to membranes accompanies regulated pore
opening but is not required for unregulated pore
conductance
CypD binding to mitochondrial membranes is reported to
increase with oxidative stress and to regulate pore opening
[11^13,30]. To determine the role of CypD membrane binding
during regulated and unregulated PT pore opening, mem-
brane bound CypD was detected by Western analysis. As
shown in Fig. 4A, when mitochondria were incubated at
room temperature for 10 min without an MPT inducer,
CypD was detected in the membrane fraction. Absorbance
measurements con¢rmed that swelling had not occurred in
these mitochondria. Similar CypD binding to membranes oc-
curred in mitochondria that were brie£y incubated on ice in
incubation bu¡er containing 5 mM dithiothreitol (DTT) and
5 mM reduced glutathione (GSH). CypD binding to mem-
branes was speci¢c, since 1 WM CsA removed virtually all
CypD from the membrane fraction.
CypD membrane binding was then determined before and
after onset of the regulated MPT. After 30 s incubation with
low-dose HgCl2 (5 WM plus 50 WM CaCl2) or alamethicin
(50 nM plus 50 WM CaCl2) before onset of the MPT, CypD
binding was the same as after 10 min of incubation after
swelling had occurred (Fig. 4A,B). Moreover, the amount of
binding in the presence of low-dose inducers was not di¡erent
from that after incubation without inducers. CsA (1 WM) also
dissociated CypD from the membrane fraction after low-dose
HgCl2 and alamethicin. CypD also bound to membranes
when mitochondria were incubated with high-dose HgCl2
(20 WM) or alamethicin (1 WM). CsA (1 WM) dissociated
CypD from membranes in the presence of high-dose inducers,
even though CsA did not block swelling (Fig. 4A,B). The
blots were stripped and reprobed for COX IV, which showed
equal protein loading for each sample.
Similar results were obtained for mitochondria incubated
with low and high doses of PhAsO and mastoparan with
and without CsA (data not shown). We also incubated the
mitochondria in a high ionic strength incubation bu¡er in
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which 100 mM KCl replaced sucrose. The amount of CypD
bound to membranes was decreased due to the increased ionic
strength, but the pattern of CypD binding was the same as in
sucrose-based bu¡er (data not shown). We also added the
chaotropic agent KSCN immediately after the incubation of
mitochondria and before freezing, as described [12,13], but we
still failed to observe an increase of CypD binding to the
membrane fraction after oxidant chemicals, including PhAsO
(0.1^200 WM), tert-butyl hydroperoxide (0.1^5 mM), and dia-
mide (0.1^1 mM) (data not shown). Although our data do not
con¢rm some earlier reports of increased CypD membrane
binding under oxidative stress [11^13], our ¢ndings do con-
¢rm other reports of CsA-sensitive CypD membrane binding
in sucrose-based bu¡er without addition of MPT inducers [30]
and of ANT/VDAC binding to CypD a⁄nity matrices in the
absence of Ca2 or oxidant chemicals [5]. Taken together,
these results indicate that CypD binds to mitochondrial mem-
branes in the absence of MPT induction and that dissociation
of CypD accompanies closure of regulated PT pores by CsA.
In contrast, CsA-induced CypD membrane dissociation did
not cause unregulated PT pore closure.
3.4. New paradigm of the PT pore as a chaperone-gated cluster
of misfolded amphipathic membrane proteins
The current model of PT pore structure proposes that PT
pores are composed of ANT, VDAC, CypD and possibly
other proteins, but this model does not account for how in-
creasing concentrations of inducers ¢rst cause opening of
regulated PT pores and subsequently unregulated pores at
higher concentrations (Fig. 1). Moreover, the current model
provides no basis for understanding how pore-like activities
can be reconstituted from di¡erent proteins and protein mix-
tures that do not depend on any single protein, including
ANT [16^18]. Indeed, we con¢rm here that completely exog-
enous pore-forming peptides like alamethicin and mastoparan
at low concentrations form regulated PT pores whose conduc-
tance properties are very similar to the PT pores induced by
low concentrations of oxidant chemicals. Moreover, these PT
pores switch to unregulated pores as do the pores induced by
oxidants (Fig. 1) [8]. Finally, the current model does not ex-
plain how unregulated pore opening occurs even when CsA
blocks CypD binding to the membrane (Fig. 4), and how
agents causing direct protein modi¢cation and damage pro-
mote pore formation.
To better accommodate the experimental facts, we propose
a new paradigm for pore composition, structure and regula-
tion to guide future investigation (Fig. 5). In our model, dam-
age after oxidative stress and other perturbations causes mis-
folding of native membrane proteins. This misfolding exposes
hydrophilic residues to the bilayer phase. These hydrophilic
surfaces cluster and enclose aqueous channels that conduct
low molecular weight solutes (Fig. 5A). Alterations to thiol
groups, particularly cross-linking of SH groups, may be crit-
ical for the initial misfolding of membrane proteins leading to
clustering [31,32]. Similarly, exogenous amphipathic peptides,
Fig. 4. E¡ect of PT inducers and CsA on CypD membrane binding.
Mitochondria (0.5 mg protein/ml) were incubated at room tempera-
ture for 30 s or 10 min in bu¡ers containing the indicated reagents,
or on ice for 30 s in a bu¡er containing 5 mM DTT and 5 mM
GSH (¢rst lanes of A and B, 0.5*). Membrane fractions were pre-
pared, and CypD content was detected by Western blotting, as de-
scribed in Section 2. Blots were stripped and reprobed with COX
IV to assess equal loading of protein. In A, mitochondria were incu-
bated with 0, 5 WM (low dose) and 20 WM (high dose) HgCl2 in the
presence or absence of 1 WM CsA. In B, mitochondria were incu-
bated with 0, 50 nM (low dose) and 1 WM (high dose) alamethicin
in the presence or absence of 1 WM CsA. 50 WM CaCl2 was added
with low-dose HgCl2 and alamethicin.
Fig. 5. New paradigm of PT pore structure and regulation. A: Mis-
folding and clustering of native membrane proteins after oxidative
damage and other perturbations expose hydrophilic residues to the
bilayer phase to enclose aqueous channels conducting low molecular
weight solutes. Exogenous amphipathic peptides also assemble into
pore-forming clusters. B: Chaperone-like proteins bind to the am-
phipathic protein clusters to block pore conductance. CypD also
binds to the clusters, perhaps to refold proteins to their native state.
Increased Ca2 causes CypD to perturb the protein cluster/chaper-
one complex to open a regulated PT pore, an e¡ect antagonized by
CsA. Opening of unregulated pores occurs when protein clusters ex-
ceed chaperones available to block their conductance.
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such as mastoparan and alamethicin, also assemble into pore-
forming clusters. As the most abundant protein in the mito-
chondrial inner membrane on a molar basis, ANT is often
involved in such amphipathic protein clustering. After the
initial formation of amphipathic protein clusters, we propose
that one or more chaperone-like proteins bind to the clusters
to block pore conductance. CypD also binds to the clusters,
perhaps to refold the proteins to their native state, which is
consistent with the cis^trans proline peptidyl isomerase activ-
ity of CypD [6]. Ca2 binding to the pore complex causes
CypD to perturb the amphipathic protein cluster/chaperone
complex to an open conductance state, an e¡ect antagonized
by CsA and Mg2. This complex of an amphipathic peptide
cluster, CypD and the as yet unidenti¢ed chaperone consti-
tutes the regulated PT pore. In addition to conferring oppos-
ing regulation by Ca2 and Mg2 and susceptibility to con-
ductance blockade by CsA, binding of chaperones and CypD
to misfolded protein clusters may confer other regulatory
properties as well, such as voltage and pH dependence
[31,33,34]. Future studies will be needed to determine whether
transformation from regulated to unregulated PT pores also
causes loss of voltage and pH dependence of pore conduc-
tance.
Although no direct evidence currently exists that a second
chaperone protein besides CypD associates with PT pore-
forming clusters, many studies indicate that chaperone pro-
teins, such as Hsp10, Hsp60 and Hsp70, protect against apo-
ptosis at the mitochondrial level by blocking cytochrome c
release into the cytosol [35,36]. Since the MPT is an important
event promoting apoptosis, these heat shock proteins repre-
sent candidate chaperones regulating PT pore function. More-
over, the association of PT pore formation with oxidative
stress and membrane protein damage also supports the possi-
ble involvement of chaperones in PT pore formation and reg-
ulation. Future studies will be needed to determine which
chaperone protein(s) interact with the PT clusters.
Opening of unregulated pores occurs when the number of
amphipathic protein clusters exceeds the number of chaper-
ones available to block their conductance (Fig. 5B). When this
occurs, the amphipathic protein clusters remain in an open
state unregulated by Ca2, CsA and Mg2. Alternatively, pro-
tein clusters may grow in size to the extent that chaperone
inhibition is overcome. However, our data indicate that aver-
age diameters of regulated and unregulated pores with various
inducers are relatively invariant, except for pores formed by
alamethicin (Fig. 3). In this chaperone-gated model, amphi-
pathic protein clusters do not constitute a single molecular
entity but will be composed of di¡erent denatured protein
or exogenous peptides depending upon the nature of MPT
induction. Thus, conductance by individual PT pores may
vary with their varying protein composition. This expectation
is consistent with a kinetic analysis of mitochondrial swelling
after the MPT, which concludes that the diameters of individ-
ual pores are heterogeneous [29].
In this model, Ca2 has two roles in PT pore formation.
First, Ca2 directly induces opening of regulated pores once
they are formed. Second, Ca2 has an independent e¡ect of
inducing oxygen radical formation by mitochondria [20,37].
Oxygen radical generation then leads to protein cross-linking,
misfolding and formation of amphipathic protein clusters. By
these two di¡erent e¡ects of Ca2, low- and high-dose Ca2
can also produce regulated (CsA-sensitive) and unregulated
(CsA-insensitive) PT pores (Fig. 2D).
Although our model is still speculative, it does account for
puzzling aspects of PT pore behavior. These aspects include
opening of regulated and unregulated PT pores by low and
high concentrations of MPT inducers, the apparent involve-
ment of a variety of unrelated proteins and peptides in PT
pore formation, the ability of unregulated PT pores to form in
the absence of CypD binding, and the association of PT pore
formation with membrane protein damage. In cell injury, al-
ternations of non-speci¢c permeability of the plasma mem-
brane also occur [38,39], and these may also be the result of
clustering of misfolded membrane proteins. Our new para-
digm provides an alternative model for pore composition
and biology that may be helpful in guiding future study of
the molecular mechanisms of cellular injury.
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